Related Experiment Videos
[A highly efficient, highly purified duck embryo rabies vaccine]
Schweizerische Medizinische Wochenschrift
|December 7, 1985
Summary
A new, highly purified rabies vaccine (PDEV) derived from duck eggs induces protective antibody titers within 14 days. This economical and efficient vaccine shows a very low risk of post-vaccinal encephalitis.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Rabies remains a significant global public health concern, necessitating effective post-exposure prophylaxis.
- Development of safe and potent rabies vaccines is crucial for disease prevention.
Purpose of the Study:
- To develop and characterize a novel, highly purified rabies vaccine derived from embryonated duck eggs (PDEV).
- To evaluate the immunogenicity and safety profile of the PDEV rabies vaccine.
Main Methods:
- Production of a purified rabies vaccine with high glycoprotein antigen content from embryonated duck eggs.
- Immunization of subjects using the WHO-recommended post-exposure schedule (6 injections).
- Assessment of antibody titers using radioimmunological methods and detection of myelin basic protein.
Main Results:
- The PDEV rabies vaccine demonstrated high immunogenicity, inducing protective antibody titers (>1 IU/ml) by day 14 post-immunization.
- Radioimmunological assays confirmed the absence of myelin basic protein in the vaccine.
- The vaccine preparation process was improved for economy and efficiency.
Conclusions:
- The PDEV rabies vaccine is a highly purified, potent, and economical option for rabies post-exposure prophylaxis.
- The vaccine elicits rapid protective immune responses with a very remote risk of post-vaccinal encephalitis.